viewGenus plc

Genus on track to meet H2 targets as trading remains strong


Animal genetics company Genus (LON:GNS) said that trading in the final two months of the financial year had been in line with expectations and it was on track to achieve an improvement in performance in the second half of the year.

Genus added that it had benefited from exchange rate movements and would report a small non-cash exceptional gain resulting from the closure to future accrual of defined benefit pensions in the Milk Pension Fund.

In a trading statement released in May, Genus reported an increased demand from customers in the North American market, which were looking to update the genetics in their herds as confidence in the strength of the recovery improved. Demand had also been strong in Latin America and China, while trading in Europe was in line with expectations.

Quick facts: Genus plc

Price: 3218 GBX

Market: LSE
Market Cap: £2.09 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



planarTECH looking to raise upwards of £500k to meet 'great deal of demand'...

planarTECH chairman Ray Gibbs speaks to Proactive London's Andrew Scott ahead of a crowdfunding campaign on Seedrs to raise around £500k as it looks to expand its current business and meet the demand it's experiencing for its graphene systems. The company was formed in 2014 and makes the...

4 hours, 4 minutes ago

2 min read